持续血糖监测设备制造商德康医疗获美国FDA选为首家参与TEMPO数字健康设备试点的公司。TEMPO项目旨在评估有助于改善慢性病管理并提供真实世界数据的新型数字健康技术。德康医疗将实施一项人工智能驱动的血糖健康计划,将Dexcom G7和Stelo设备的数据与营养、身体活动、睡眠及压力等情境化健康信息相结合,从而为医疗专业人员和符合条件的用户提供更具个性化的洞察。
持续血糖监测设备制造商德康医疗获美国FDA选为首家参与TEMPO数字健康设备试点的公司。TEMPO项目旨在评估有助于改善慢性病管理并提供真实世界数据的新型数字健康技术。德康医疗将实施一项人工智能驱动的血糖健康计划,将Dexcom G7和Stelo设备的数据与营养、身体活动、睡眠及压力等情境化健康信息相结合,从而为医疗专业人员和符合条件的用户提供更具个性化的洞察。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.